USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ANALIZA, INC.
Address:
ANALIZA, INC.
408 GLEN PARK DR
BAY VILLAGE, OH 44140
Phone:
(440) 808-8708
URL:
N/A
EIN:
341827749
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $580,337.00 8
SBIR Phase II $1,826,678.00 4

Award List:

DEVELOPMENT OF A HUMANE TATTOO SYSTEM FOR VISUAL AND INSTRUMENTAL PERMANENT IDENTIFICATION OF SMALL RODENTS.

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

DEVELOPMENT OF A HUMANE TATTOO SYSTEM FOR VISUAL AND INSTRUMENTAL PERMANENT IDENTIFICATION OF SMALL RODENTS.

Award Year / Program / Phase:
1989 / SBIR / Phase II
Award Amount:
$349,688.00
Agency:
HHS
Principal Investigator:
Abstract:
This phase 1 project will result in development of pigments, tattoo equipment and procedures for visual and instrumental identification of dark colored rodents. the b6c3f1 brown mouse will be used as a model. various black and colored pigments will be evaluated along with light sources for visual… More

DEVELOPMENT OF HUMANE TATTOO SYSTEM OF SMALL RODENTS

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$16,252.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

DEVELOPMENT OF HUMANE TATTOO SYSTEM OF SMALL RODENTS

Award Year / Program / Phase:
1991 / SBIR / Phase II
Award Amount:
$349,688.00
Agency:
HHS
Principal Investigator:
Abstract:
The phase i project resulted in the development of several tattoo pigments that were effective in identifying b6c3f1 brown mice in a 3-month study. these pigments did not affect growth or mortality; however, one pigment was cytotoxic to in vitro mouse lymphoma cells. the phase ii project will… More

NEW METHOD FOR MEASUREMENT OF CDT LEVEL IN SERUM

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$99,750.00
Agency:
HHS
Principal Investigator:
Zaslavsky, boris y
Abstract:
DESCRIPTION: (Adapted from the applicant's abstract) The innovation described in this proposal is aimed at providing a new method for detection of carbohydrate-deficient transferrin (CDT) in human blood as a biochemical marker of alcohol abuse. CTD has been extensively shown to be a sensitive and… More

MICROHETEROGENEITY IN BIOPRODUCTS

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$99,938.00
Agency:
HHS
Principal Investigator:
Zaslavsky, boris y
Abstract:
The innovation described in this proposal is aimed at providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potency of a drug is governed by the chemical structure for both traditional drugs and biopharmaceuticals.… More

NEW METHOD FOR QSAR FOR BIOPHARMACEUTICAL PRODUCTS

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$94,588.00
Agency:
HHS
Principal Investigator:
Zaslavsky, boris y
Abstract:
N/a

MICROHETEROGENEITY IN BIOPRODUCTS

Award Year / Program / Phase:
1998 / SBIR / Phase II
Award Amount:
$749,995.00
Agency:
HHS
Principal Investigator:
Zaslavsky, boris y
Abstract:
The innovation described in this proposal is aimed at providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potency of a drug is governed by the chemical structure for both traditional drugs and biopharmaceuticals.… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Boris Y. Zaslavsky
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$377,307.00
Agency:
HHS
Principal Investigator:
Boris Y. Zaslavsky
Abstract:
N/a

RAPID QUALITY CONTROL TECHNOLOGY FOR BIODEFENSE VACCINES

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,242.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (Provided by applicant): Due to the anticipated significant increase in the number of potential vaccines for CDC Category A agents in the near future, it is imperative that a rapid response quality control technology be developed and validated. The key objective of this proposal is to… More

Structural Signatures for Quality Control of Proteins

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$120,567.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Higher-order structural information for biomolecules is an important component of quality control activities for recombinant proteins. Unfortunately, detailed structural information typically require highly complex, time-consuming experimental techniques (e.g.,… More